| Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India B Jolly, N John, RC Bhoyar, N Majeed, V Senthivel, CP Fairoz, M Rophina, ... Journal of Infection 83 (2), 237-279, 2021 | 67 | 2021 |
| Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India UB Singh, M Rophina, R Chaudhry, V Senthivel, K Bala, RC Bhoyar, ... Journal of medical virology 94 (4), 1696-1700, 2022 | 28 | 2022 |
| ESC: a comprehensive resource for SARS-CoV-2 immune escape variants M Rophina, K Pandhare, A Shamnath, M Imran, B Jolly, V Scaria Nucleic acids research 50 (D1), D771-D776, 2022 | 21 | 2022 |
| Initial insights into the genetic epidemiology of SARS-CoV-2 isolates from Kerala suggest local spread from limited introductions C Radhakrishnan, MK Divakar, A Jain, P Viswanathan, RC Bhoyar, ... Frontiers in genetics 12, 630542, 2021 | 20 | 2021 |
| Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes B Jolly, M Rophina, A Shamnath, M Imran, RC Bhoyar, MK Divakar, ... BioRxiv, 2020.12. 24.424332, 2020 | 16 | 2020 |
| SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker A Gupta, R Bhoyar, S Mirza, B Jolly, V Senthivel, A Shamnath, MK Divakar, ... The Journal of Infection 84 (3), 418, 2022 | 7 | 2022 |
| FaviCoV-a comprehensive manually curated resource for functional genetic variants in SARS-CoV-2 M Rophina, K Pandhare, M Mangla, A Shamnath, B Jolly, M Sethi, ... FaviCoV-a comprehensive manually curated resource for functional genetic …, 2020 | 4 | 2020 |
| Clinical characteristics of AY. 4 infections are similar to B. 1.617. 2 infections: a preliminary study R Das, R Karyakarte, S Joshi, S Joshi, S Khan, P Kadam, N Shah, ... Indian J Bas App Med Res 11, 110-22, 2021 | 1 | 2021 |
| Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India A Joseph, MK Divakar, PR Nair, A Shamnath, PJ Kumar, A Jain, P Geetha, ... | | |
| Persistent SARS-CoV-2 infections in Immunocompromised hosts contribute to new variants UB Singh, M Imran, R Chaudhry, B Jolly, K Bala, V Senthivel, A Srivastav, ... | | |
| What did we learn from the SARS-CoV-2 vaccine breakthrough infections A Shamnath, M Rophina, B Jolly, RC Bhoyar, S Sivasubbu, V Scaria | | |
